ObvioHealth
Financials
Estimates*
USD | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
Revenues | 3.4m | 3.7m | 9.4m | 27.2m | 40.5m |
% growth | - | 9 % | 154 % | 190 % | 49 % |
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$2.3m | Seed | ||
$6.0m | Seed | ||
* | $17.0m | Early VC | |
$17.0m | Series A | ||
* | $31.0m | Late VC | |
N/A | N/A | Series C | |
* | N/A | $15.0m Valuation: $155m | Late VC |
Total Funding | $88.3m |
Recent News about ObvioHealth
EditObvioHealth is a digital health organization specializing in conducting virtual clinical trials. The company operates in the healthcare and pharmaceutical sectors, serving clients such as pharmaceutical companies, healthcare providers, and research institutions. ObvioHealth's proprietary platform and mobile application enable participants to engage in clinical studies from the comfort of their homes, ensuring safety and convenience. This approach allows for the collection of comprehensive and accurate data sets that reflect real-world behaviors. The business model is based on providing end-to-end solutions for clinical trials, from participant recruitment to data analysis, thereby generating revenue through service contracts and strategic partnerships. ObvioHealth's innovative approach not only enhances participant compliance but also accelerates the research process, making it more efficient and cost-effective. The company is committed to improving health outcomes by delivering high-quality, real-world evidence that substantiates product claims and informs strategic decisions.
Keywords: virtual trials, digital health, clinical research, real-world data, pharmaceutical, healthcare, mobile application, participant recruitment, data analysis, strategic insights.